Advertisement
Screener

Harrow, Inc. (HROW) Additional Paid in Capital, Common Stock

Harrow, Inc. Additional Paid in Capital, Common Stock

Harrow, Inc. (HROW) had Additional Paid in Capital, Common Stock of $96.77 million as of 2018-09-30, per its 10-Q filed 2018-11-13.

Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2018-11-13

  • 2018-09-30: Additional Paid in Capital, Common Stock $96.77M.
  • 2017-12-31: Additional Paid in Capital, Common Stock $91.43M.
  • 2017-09-30: Additional Paid in Capital, Common Stock $89.79M.
  • 2017-06-30: Additional Paid in Capital, Common Stock $88.00M.
Period endAdditional Paid in Capital, Common StockAdditional Paid in Capital, Common Stock as first filed
2018-09-30$96.77M
10-Q · filed 2018-11-13
2017-12-31$91.43M
10-Q · filed 2018-11-13
2017-09-30$89.79M
10-Q · filed 2017-11-14
2017-06-30$88.00M
10-Q · filed 2017-08-10
2017-03-31$87.15M
10-Q · filed 2017-05-10
2016-12-31$83.26M
10-Q · filed 2017-11-14
2016-09-30$73.57M
10-Q · filed 2016-11-14
2016-06-30$72.49M
10-Q · filed 2016-08-15
2016-03-31$71.03M
10-Q · filed 2016-05-12
2015-12-31$56.37M
10-K · filed 2017-03-21
2015-09-30$54.87M
10-Q · filed 2015-11-12
2015-06-30$53.92M
10-Q · filed 2015-08-12
2015-03-31$51.16M
10-Q · filed 2015-05-13
2014-12-31$50.01M
10-K · filed 2016-03-23
$50.01M
10-K · filed 2015-03-12
2014-09-30$49.39M
10-Q · filed 2014-11-12
2013-12-31$46.85M
10-K · filed 2015-03-12
2007-12-31$175.00K
10-K · filed 2014-03-28
2006-12-31$400.00K
10-K · filed 2014-03-28
2005-12-31$400.00K
10-K · filed 2014-03-28
2004-12-31$400.00K
10-K · filed 2014-03-28
2003-12-31$200.00K
10-K · filed 2014-03-28
2002-12-31$200.00K
10-K · filed 2014-03-28
2001-12-31$200.00K
10-K · filed 2014-03-28
2000-12-31$200.00K
10-K · filed 2014-03-28
1999-12-31$200.00K
10-K · filed 2014-03-28
1998-12-31$100.00K
10-K · filed 2014-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Kardigan, Inc. (KARD)United States$1.346B